Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

DGAP-Adhoc: SHOP APOTHEKE EUROPE raises full year 2020 guidance.


DGAP-Ad-hoc: SHOP APOTHEKE EUROPE N.V. / Key word(s): Change in Forecast/Forecast
SHOP APOTHEKE EUROPE raises full year 2020 guidance.

23-Jul-2020 / 18:42 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


SHOP APOTHEKE EUROPE raises full year 2020 guidance.

According to preliminary calculations, SHOP APOTHEKE EUROPE has significantly improved its key earnings figures in the second quarter of 2020 in line with the increased business volume. Based on the developments in the first and second quarters and against the background of an overall slightly improved visibility for the remaining part of the year, SHOP APOTHEKE EUROPE is lifting its guidance for the 2020 financial year.

For the full year, the Management Board now expects a sales growth of at least 30% compared to the financial year 2019 (previously: at least 20%) and a positive adjusted EBITDA margin in the range of 1-2% (previously: a positive adjusted EBITDA).

SHOP APOTHEKE EUROPE will publish the full report for the first half of 2020 on August 6, 2020.

 

Contact:
rikutis consulting
Thomas Schnorrenberg
Cel: +49 151 46 53 13 17
E-Mail: [email protected]

23-Jul-2020 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: SHOP APOTHEKE EUROPE N.V.
Dirk Hartogweg 14
5928 LV Venlo
Netherlands
Phone: 0800 - 200 800 300
Fax: 0800 - 90 70 90 20
E-mail: [email protected]
Internet: www.shop-apotheke-europe.com
ISIN: NL0012044747, DE000A19Y072
WKN: A2AR94, A19Y07
Indices: SDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1100793

 
End of Announcement DGAP News Service

1100793  23-Jul-2020 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1100793&application_name=news&site_id=sharewise

Shop Apotheke Europe NV Stock

€130.50
0.380%
The Shop Apotheke Europe NV stock is trending slightly upwards today, with an increase of €0.50 (0.380%) compared to yesterday's price.
With 6 Buy predictions and not the single Sell prediction the community is currently very high on Shop Apotheke Europe NV.
With a target price of 154 € there is a slightly positive potential of 18.01% for Shop Apotheke Europe NV compared to the current price of 130.5 €.
Like: 0
Share
EQS Group is a leading international provider of regulatory technology in the fields of corporate compliance and investor relations. In working with EQS Group, thousands of companies worldwide inspire trust by fulfilling complex national and international disclosure obligations, minimizing risks and communicating transparently with stakeholders.




Legal notice

Comments